← Back to Search

Behavioral Intervention

Single-Session Intervention for Child Anxiety (aSSI Trial)

N/A

Recruiting

Research Sponsored by Florida International University

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be younger than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 1 week after first session

Awards & highlights

aSSI Trial Summary

This trial will study if a single session intervention can help reduce anxiety in youth on waitlists for treatment, with the aim of increasing accessibility & scalability of treatment for youth anxiety.

Who is the study for?

This trial is for families with children aged 7-17 who are on waitlists for anxiety treatment and show significant anxiety symptoms, as reported by parents or the children themselves using a specific questionnaire (SCARED-C/P).Check my eligibility

What is being tested?

The study tests a single session intervention (SSI) module designed to educate about anxiety and teach self-regulation and cognitive restructuring techniques. It includes parental guidance on supporting their anxious child. Families will be randomly assigned to either receive this SSI or remain on the waitlist.See study design

What are the potential side effects?

Possible discomforts include feeling uneasy discussing personal feelings and behaviors during research activities, along with the risk of confidentiality breaches potentially revealing participants' identities as individuals experiencing high levels of anxiety.

aSSI Trial Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 1 week after first session

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~1 week after first session

This trial's timeline: 3 weeks for screening, Varies for treatment, and 1 week after first session for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Screen for Child Anxiety Related Emotional Disorders - Child Version at Follow-Up

Screen for Child Anxiety Related Emotional Disorders - Child Version at posttreatment

Screen for Child Anxiety Related Emotional Disorders - Parent Version at Follow up

+1 more

Secondary outcome measures

Child Anxiety Impact Scale - Child Version at Follow Up

Child Anxiety Impact Scale - Child Version at Posttreatment

Child Anxiety Impact Scale - Child Version at Pre

+15 more

aSSI Trial Design

2Treatment groups

Active Control

Group I: Single Session Intervention ReceiversActive Control1 Intervention

Participants complete pre then receive the SSI module. Then they complete post and follow-up questionnaires.

Group II: Waitlist ControlActive Control1 Intervention

Participants complete pre, post, and follow-up questionnaires. They have the option to view the SSI module after completing follow-up questionnaires.

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

Florida International UniversityLead Sponsor

100 Previous Clinical Trials

17,490 Total Patients Enrolled

8 Trials studying Anxiety Disorders

1,395 Patients Enrolled for Anxiety Disorders

Media Library

SSI Module (Behavioral Intervention) Clinical Trial Eligibility Overview. Trial Name: NCT05841680 — N/A

Anxiety Disorders Research Study Groups: Single Session Intervention Receivers, Waitlist Control

Anxiety Disorders Clinical Trial 2023: SSI Module Highlights & Side Effects. Trial Name: NCT05841680 — N/A

SSI Module (Behavioral Intervention) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05841680 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is this research venture enrolling individuals over the age of fifty?

"All potential participants have to be between the ages of 7 and 17 in order to qualify for this trial. There are 110 studies recruiting individuals under 18 years old, while 291 require a minimum age of 65."

Answered by AI

Is this research effort still enrolling participants?

"The clinicaltrial.gov database indicates that this medical experiment is currently enrolling participants, with the original posting occurring on February 10th 2023 and the most recent update issued within April 24th of the same year."

Answered by AI

What is the aggregate participant count for this experiment?

"Affirmative. Clinicaltrials.gov records suggest that this trial, initially posted on February 10th 2023, is actively enrolling patients. 65 participants need to be recruited from one medical site."

Answered by AI

Who is eligible to participate in this experiment?

"This study seeks 65 participants who suffer from anxiety disorders and are aged between 7-17 years old."

Answered by AI

What tangible results is this research seeking to achieve?

"This clinical trial's primary objective is to assess the efficacy of Screen for Child Anxiety Related Emotional Disorders - Child Version (SCARED-C) at posttreatment. The secondary objectives include appraising SCARED-C pre-intervention, as well as the Parent and Child versions of the Child Anxiety Impact Scale (CAIS-P & CAIS-C), which measure anxiety related functional impairment in both parents and children over a month long period. All three scales range from 0 to 81, with higher scores denoting greater severity or impairment."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

A Single-Session Intervention for Families on Waitlists for Child Anxiety Treatment

2023. "A Single-Session Intervention for Families on Waitlists for Child Anxiety Treatment". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05841680.

All > Anxiety Disorder